ACE-031 (ActRIIB-Fc)

ACE-031 is an experimental recombinant fusion protein consisting of the extracellular domain of Activin Type IIB Receptor (ActRIIB) fused to an immunoglobulin Fc domain. Unlike conventional short-chain research peptides, ACE-031 is more accurately characterized as an ActRIIB-Fc fusion protein.

ActRIIB interacts with several members of the TGF-β superfamily, including myostatin (GDF-8) and certain activins. These signaling pathways are closely associated with skeletal muscle growth, muscle tissue homeostasis, cellular differentiation, and related biological processes.

In life science research, ACE-031 is investigated in connection with myostatin/ActRIIB signaling, activin-related pathways, skeletal muscle biology, regulation of muscle growth, and TGF-β superfamily signaling. It can also serve as a research tool for studying ligand-receptor interactions and their downstream biological effects.

ACE-031 has previously undergone human clinical investigation but has not become an approved therapeutic product. It should therefore not be represented as having established muscle-building or performance-enhancing effects in humans.

La livraison est facturée selon le nombre d'articles de la commande, aux mêmes tarifs pour toutes les destinations, et le montant exact s'affiche au moment du paiement, avant de payer. Expédition sous 1 jour ouvré.

Pas convaincu ? Renvoyez le produit sous 30 jours pour un remboursement intégral, même ouvert.